Overview
The Swede score is a numeric colposcopic index used to describe visible cervical findings after 3–5% acetic acid and, when appropriate, Lugol iodine. It assigns 0, 1, or 2 points to each of five domains, so the total ranges from 0 to 10. The system was introduced to reduce unstructured, narrative colposcopy reports and to align bedside description with the likelihood of significant histology—particularly high-grade cervical intraepithelial neoplasia (CIN2 or worse)—in studied cohorts.
This calculator applies the original Strander formulation as widely reproduced in colposcopy education. It is intended for documentation, training, and shared clinical language; it does not replace histologic diagnosis or replace national or regional guidelines for managing abnormal cervical cancer screening results.
Why structured colposcopy scoring matters
Colposcopy is inherently subjective. Two experienced examiners may use different words for the same image, and the same words may imply different severity. That variability complicates audit, research, multidisciplinary communication, and quality assurance. Structured scores translate visual patterns into a repeatable ordinal summary while still requiring clinical judgment about which pattern best fits the lesion.
Scores such as the Swede system also help learners move from pattern recognition alone toward explicit criteria: how opaque the acetowhite change is, how the margin behaves, what the vessels look like, how large the lesion is, and how the epithelium takes up iodine. When those elements are scored separately, the total reflects combined colposcopic burden rather than a single global impression.
Relation to the Reid colposcopic index
The Swede score is closely related to the modified Reid colposcopic index, which historically emphasized acetowhiteness, margin characteristics, vascular patterns, and iodine staining. The Swede system’s distinctive addition is a formal lesion size domain. Large surface area and involvement of multiple quadrants—or extension into the endocervical canal without a fully visible upper margin—often track with more advanced disease in colposcopic series. Encoding size in the score acknowledges that extent is not merely a footnote to color or vessels but an independent component of the colposcopic picture.
The five domains in detail
1. Acetic acid uptake (acetowhite change)
After brief application of dilute acetic acid, abnormal epithelium dehydrates and nuclei condense, producing a temporary whitening relative to surrounding mucosa. The intensity and character of that change are scored:
- 0 points — Transparent / no acetowhite change: No convincing whitening attributable to epithelial abnormality in the area of interest, or change so minimal that it does not meet the “milky” threshold.
- 1 point — Shady / milky white: Visible whitening that is hazy or intermediate—not fully transparent, but not the dense, “chalky” appearance of the highest tier.
- 2 points — Distinct, opaque white: Clearly demarcated, dense acetowhite change that stands out sharply from the background. This tier reflects stronger optical contrast and, in many teaching frameworks, raises concern for higher-grade change when combined with other high-score features.
Inflammation, healing epithelium, and metaplasia can mimic acetowhite change; correlation with cytology, human papillomavirus (HPV) testing, prior treatments, and the time course of findings reduces misclassification.
2. Margins and surface contour
How the acetowhite area meets normal epithelium provides diagnostic texture. The Swede score distinguishes diffuse from sharply bordered patterns and whether the surface is level or stepped:
- 0 points — Diffuse: Poorly circumscribed edges, feathering, or a gradual transition without a clear line between abnormal and normal epithelium.
- 1 point — Sharp but irregular: A visible border that is angular, jagged, “geographical,” or associated with small satellite patches adjacent to the main lesion.
- 2 points — Sharp and even with surface level difference: A smooth, sharp demarcation often accompanied by a perceptible step or “cuffing” at the margin—findings emphasized in colposcopic teaching as worrisome for high-grade epithelial abnormality when other domains align.
Margin assessment benefits from standardized magnification, adequate focal plane, and minimizing glare; out-of-focus images can falsely appear diffuse or irregular.
3. Vessels (after acetic acid)
Vascular pattern reflects capillary architecture in the subepithelial stroma. The Swede schema assigns:
- 0 points — Fine, regular vessels: Normal-appearing branching or hairpin loops without coarse mosaicism or punctuation.
- 1 point — Vessels absent in the lesion area: In the published Swede system, absence within the abnormal field scores intermediate. This reflects the original index logic rather than an intuitive “no vessels = benign” rule; interpretation always depends on the composite score and clinical context.
- 2 points — Coarse or atypical vessels: Irregular mosaic, punctuation, or other coarse patterns suggesting disrupted epithelial–stromal architecture.
Bleeding, mucus, or patient movement can obscure vessels; repeating application of acetic acid or gentle cleansing may be needed before scoring.
4. Lesion size
Extent is scored using both linear size and quadrant involvement, with an explicit pathway for endocervical disease:
- 0 points — Smaller than 5 mm: Very focal change.
- 1 point — 5–15 mm or spanning two quadrants: Intermediate area by either metric.
- 2 points — Larger than 15 mm, three or four quadrants, or endocervical extension not fully defined: Large surface involvement or an invisible upper limit of disease inside the canal—situations that often trigger more aggressive biopsy or excision planning under guideline-based care even before histology returns.
When multiple discrete lesions are present, aggregate the clinically dominant pattern per your local protocol; consistency matters more than minor differences in counting satellites.
5. Iodine staining (Lugol)
Glycogen-rich squamous epithelium stains dark brown with iodine. Abnormal or immature epithelium often fails to bind iodine well and appears yellow or non-staining relative to the background:
- 0 points — Brown: Uniform uptake consistent with mature, glycogenated squamous epithelium in the assessed field.
- 1 point — Faint or patchy yellow: Intermediate iodine negativity—heterogeneous or subtle.
- 2 points — Distinct yellow: Clearly iodine-negative epithelium in the lesion relative to surrounding brown mucosa.
Pregnancy, atrophy, inflammation, and recent vaginal products can alter iodine uptake independent of neoplasia. If iodine is not applied—for example, in selected clinical scenarios—your documentation should state that the iodine domain was not scored rather than defaulting to zero without comment.
Computing the total score
Add the points from all five domains. The theoretical range is 0–10. A score of 0 describes a colposcopic picture with minimal abnormal features across domains, whereas 10 represents the maximum coded abnormality in each category simultaneously—uncommon but possible in extensive high-grade disease.
| Domain | Points per domain |
|---|---|
| Acetic acid uptake | 0–2 |
| Margins and surface | 0–2 |
| Vessels | 0–2 |
| Lesion size | 0–2 |
| Iodine staining | 0–2 |
| Total (Swede score) | 0–10 |
How totals are used in practice (evidence-informed, not prescriptive)
Validation studies differ by population, referral intensity, HPV primary versus cytology-based screening era, and histologic endpoint (CIN2+ versus CIN3+). In aggregate, higher Swede scores correlate with higher probabilities of significant histology, while very low scores correlate with lower probabilities in reported cohorts—never with zero risk.
Published work has often highlighted that a high cutoff (commonly discussed around ≥8) can be associated with high specificity for CIN2 or worse in certain datasets, meaning many people below that threshold did not have high-grade disease in those studies. Specificity at that range typically trades off against sensitivity: some high-grade lesions present with lower colposcopic scores because of location (endocervix), focality, inflammation, or prior therapy.
Scores in the mid range frequently require integration with HPV genotype, cytology severity, prior biopsy results, immunosuppression, age, and fertility preferences. Scores in the lower range still merit follow-up when screening triggers are high-risk—for example severe cytology or persistent oncogenic HPV—because colposcopy is an imperfect mirror of histology.
Documentation, training, and quality improvement
Beyond risk estimation, the Swede score excels as a teaching and audit tool. Trainees can compare their domain-by-domain choices with attendings, and services can track whether high scores align with biopsy yield over time. Electronic health record templates that embed the five rows reduce missing data and make multidisciplinary tumor boards easier to navigate when cervical pathology is discussed.
Limitations and situations that distort scoring
- Inflammation and infection can produce acetowhite change and abnormal vessels that resolve with treatment, falsely raising the score.
- Prior excision, ablation, or radiation alters mucosal architecture and iodine uptake.
- Pregnancy increases ectopy and vascularity; interpret cautiously.
- Small focal high-grade lesions may occupy a tiny area with subtle margins yet still be clinically important—size alone does not exhaust risk.
- Observer variability persists even with structured systems; photography and second-read policies can help.
Using this calculator responsibly
Enter the option that best matches each domain after standard colposcopic examination. The output summarizes the numeric total and groups scores into broad bands for educational orientation. Always apply the result within your institution’s pathway for colposcopy, biopsy, excision, and surveillance, and confirm management with histology when tissue is obtained.